The nitrogen assimilation control protein (NAC) from Klebsiella pneumoniae is a typical LysR-type transcriptional regulator (LTTR) in many ways. However, the lack of a physiologically relevant coeffector for NAC and the fact that NAC can carry out many of its functions as a dimer make NAC unusual among the LTTRs. In the absence of a crystal structure for NAC, we analyzed the effects of amino acid substitutions with a variety of phenotypes in an attempt to identify functionally important features of NAC. A substitution that changed the glutamine at amino acid 29 to alanine (Q29A) resulted in a NAC that was seriously defective in binding to DNA. The H26D substitution resulted in a NAC that could bind and repress transcription but not activate transcription. The I71A substitution resulted in a NAC polypeptide that remained monomeric. NAC tetramers can bind to both long and shorter binding sites (like other LTTRs). However, the absence of a coeffector to induce the conformational change needed for the switch from the former to the latter raised a question. Are there two conformations of NAC, analogous to the other LTTRs? The G217R substitution resulted in a NAC that could bind to the longer sites but had difficulty in binding to the shorter sites, and the I222R and A230R substitutions resulted in a NAC that could bind to the shorter sites but had difficulty in binding properly to the longer sites. Thus, there appear to be two conformations of NAC that can freely interconvert in the absence of a coeffector.
The LysR-type transcriptional regulator (LTTR) family contains the highest number of regulatory proteins in the bacterial world, with more than 23,000 identified in the completed bacterial genome sequences as of March 2009 (43) . They are assembled as tetramers, which are in fact dimers of dimers (27, 39) . Like many transcriptional regulators, they contain two well-defined domains, an N-terminal DNA-binding domain and a C-terminal regulatory domain responsible for dimerdimer interactions and for binding a regulatory coeffector. This coeffector is usually a small molecule that, when bound, moves the DNA-binding domains of the two dimers closer together such that a shorter DNA-binding site is recognized in the presence of the coeffector than in its absence (29, 42, 45, 47) . Despite their abundance, few LTTRs have been crystallized and even fewer structures are available. Complete structures of CbnR, and more recently TsaR and ArgP, have been solved at high resolution (28, 29, 48) , and a complete DntR structure has also been solved, although its DNA-binding domain was less well resolved (42) . The C-terminal domains of several other LTTRs have been crystallized and their structures solved, but only after the DNA-binding domain was removed (6, 7, 44, 46) . Unfortunately, no full-length LTTR structure has been solved in both the coeffector-bound and coeffector-free conformations, leaving us to extrapolate the effects seen from the Cterminal domain structures, where both forms have been solved in several cases (see references 6, 7, and 42 for examples).
The nitrogen assimilation control protein, NAC, from Klebsiella pneumoniae is in many ways a typical LTTR. It shows sequence similarity to the family (40) , it is a dimer of dimers (38) , it activates some genes and represses others (25, 41) , it has the typical two domains (31, 40) , and it has proved recalcitrant to our attempts at crystallization. But in other ways, NAC is a special case among the LTTRs. At most of the sites where NAC activates transcription, it functions as a dimer (18, 38) . Other functionally dimeric LTTRs are known, e.g., MetR (23) ; however, even these LTTRs usually function in their tetrameric state to activate transcription. Truncated versions of NAC with as few as 86 amino acids (of the 305 total) are able to activate transcription at many, if not all, sites (31, 38) . The NAC regulon is unusually large, with scores of genes binding and responding to NAC-mediated activation or repression (11) . NAC has no physiologically relevant coeffector (13, 41) . The decision to activate or repress gene expression is determined solely by whether NAC is made and not by a differential activity of the NAC once made (41) . Although NAC tetramers can recognize both longer and shorter binding sites (like other LTTRs), it does so without the intervention of any coeffector or modification (37) . This suggested that NAC tetramers can undergo a conformational change from a more compact to a more extended form in response to the DNA site presented to them, a conformational change that corresponds to the change induced by the binding of coeffectors in other LTTRs (37) .
In addition, we have postulated a conformational change that occurs when a NAC dimer interacts with its binding site to activate transcription (35) . The NAC-binding sites (NBS) at the hutU promoter (NBS hutU ) and the ureD promoter (NBS ureD ) are functionally asymmetric (10, 35) . Inverting the site (from ATAA-N5-TnGTAT to ATACnA-N5-TTAT) leads to loss of activation. Making the sites symmetric for the halfsite nearest the start of transcription (ATACnA-N3-TnGTAT) results in a functional site. However, making the sites symmetric for the other half-site (ATAA-N7-TTAT) allows NAC to bind well, but the binding is ineffective and transcriptional activation is lost (10, 35) . It is not known whether the conformational change that occurs when a dimer binds has any effect on the conformational change that involves reorientation of the dimers within the tetramer to allow recognition of the longer or shorter tetramer-binding sites.
In the absence of a crystal structure for NAC, we embarked on a genetic analysis to identify functionally important elements of NAC and to determine whether these features were consistent with the structural elements defined for other LTTRs.
MATERIALS AND METHODS
Strains and plasmids. All K. pneumoniae strains used here were derived from strain W70, which was originally called K. aerogenes (26) . Strains KC4598 (hutC515 ⌬ Plasmid pCB1041 (38) is a low-copy-number vector (six to eight copies in Escherichia coli) that confers ampicillin resistance and allows expression of cloned material from a lacZ promoter (ultimately derived from plasmid pUC8). Plasmid pCB1051 is pCB1041 with an EcoRI-SalI fragment that puts a wild-type nac gene under the control of the lacZ promoter. Plasmid pCB1026 (38) is the expression vector pQE70 (Qiagen) with an EcoRI-BamHI fragment containing a nac gene with six histidine codons fused to the 3Ј end of the gene. Plasmid pCB797 is pBCKSϩ (Stratagene) with an EcoRI-HindIII fragment that carries a wild-type nac gene with six histidine codons added to the 3Ј end of the gene. Plasmid pCB1560 is plasmid pKSM13(ϩ) (Stratagene) with NBS hutU cloned as the EcoRI-HindIII fragment from pOS1 (33) .
Enzyme assays. Cultures of K. pneumoniae were grown in W4 minimal medium (25) supplemented with glucose (0.4%, wt/vol), ammonium sulfate (0.2%, wt/vol), L-glutamine (0.2%, wt/vol), nickel sulfate (2 M), and ampicillin (100 g/ml). L-Lysine (0.01%, wt/vol) was also added to some of the cultures, as indicated below in Table 3 . Histidase, glutamate dehydrogenase, urease, and ␤-galactosidase were assayed in cells made permeable with detergent as described previously (25) . Specific activities are reported as nmol of product formed or of substrate consumed per min per mg of cellular protein, as measured by the Lowry assay (24) . The values reported are the averages from three or more independent cultures, with standard errors of the means (SEM) that were less than 20% of the mean in all cases (as noted in the table footnotes).
Site-directed mutagenesis. Alanine scanning mutagenesis was performed using the GeneEditor kit (Promega) according to the manufacturer's directions. Each mutation was introduced in plasmid pCB1051. E. coli strain DH5␣ was transformed with the mutagenized plasmids, and candidate colonies were saved. Plasmid DNA from these candidates was submitted for DNA sequence analysis at the University of Michigan DNA Sequencing Core. Plasmid DNA containing the desired mutation was used to transform strain DH5␣, and these secondary transformants were saved. Minipreps of the plasmid DNA from these secondary transformants were used to transform the Nac Ϫ K. pneumoniae strain KC4598. Plasmid DNA from the transformed KC4598 strains was submitted for DNA sequence analysis to confirm that the nac gene was present as expected, and these transformants were used for the assays reported below in Table 1 . Plasmid DNA was prepared from each strain that showed a phenotype other than wild type (see Table 1 ). An EcoRI-Eco47III fragment, which carried the N-terminal region of the nac gene, was then subcloned into plasmid pCB797. This yielded a Cterminally His-tagged version of the mutant nac gene. When mutant NAC protein was to be isolated, the N-terminal region of the nac coding sequence was cloned as an EcoRI-HindIII fragment from the pCB797-derived clones into plasmid pQE70 (Qiagen). All clones in pQE70 were submitted for DNA sequencing to confirm the integrity of the (mutant) nac gene sequence.
Arginine scanning mutagenesis was performed similarly using plasmid pCB1051 as starting material. Secondary transformants were saved in E. coli strain DH5␣, and DNA from these strains was used to transform K. pneumoniae strain KC4727 for the assays reported below in Table 3 .
Protein purification. His-tagged wild-type and mutant NAC proteins were purified by nickel affinity chromatography as described previously (38) . After elution from the nickel resin, the eluate was dialyzed overnight against buffer 4 (250 mM NaCl, 100 mM sodium phosphate [pH 7.0], 2.5 mM MgCl 2 , 1 mM ␤-mercaptoethanol) to remove the imidazole used for elution from the column. The resulting protein was concentrated using Centricon filters according to the manufacturer's directions and either used immediately or stored at 20°C in buffer 4 containing 50% glycerol. The protein concentration was measured by using the method of Lowry (24) .
Gel filtration. A 250-ml sample of His-tagged wild-type NAC (NAC   WT   ) or of a His-tagged mutant NAC (NAC L111K or NAC
I71A
) was applied to a Sephadex S200 fast-performance liquid chromatography (FPLC) gel filtration column (Amersham Pharmacia Biotech) equilibrated with buffer 4. Protein eluting from the column was detected by monitoring absorbance at 280 nm.
Radioactive electrophoretic mobility shift assay (EMSA). For the experiments shown below in Fig. 1 and 5, DNA fragments were isolated and labeled with [␣-32 P]dATP by using Klenow fragment (Roche) according to the manufacturer's instructions. Labeled DNA fragments were incubated with His-tagged NAC in a 10-l reaction mixture containing 50 mM Tris-HCl (pH 7.5), 10 g of bovine serum albumin (BSA), and 20 nM poly(dI ⅐ dC). After 20 min of incubation at 30°C, 1 l of loading buffer (40 mM Tris-HCl [pH 8.4], 4 mM EDTA, 0.2% bromophenol blue, 0.2% xylene cyanol, 25% glycerol) was added. Bound and unbound fragments were separated by electrophoresis on a Tris-borate-EDTA-5% polyacrylamide gel at 13 V/cm for 3 h. The gel was transferred to Whatman 3MM filter paper and dried. Autoradiograms were obtained by exposing the dried gels to X-ray film at Ϫ70°C with an intensifying screen.
Nonradioactive EMSA. When the use of higher concentrations of protein and DNA would not interfere with the interpretation of the results (e.g., the experiments shown below in Fig. 3 and 7) , a nonradioactive EMSA was used. DNA was prepared by PCR amplification using primers that generated a 150-bp fragment with the NBS at the approximate center of the fragment. Plasmid pOS1 (33) was used as template for NBS hutU , plasmid pJF200 (8) was used as template for NBS nac , and pCB816 (32) was used as template for NBS codB . Histidine-tagged wild-type or mutant NAC protein was mixed with DNA in buffer 4 in the presence of 10 g of BSA. The reaction volume was 10 l, the DNA amounts were generally in the range of 30 to 45 ng, and the protein amounts were generally adjusted to allow shifting of about half of the input DNA. After 20 min of incubation at room temperature, 1.5 l of loading buffer (40 mM Tris-HCl [pH 8.4], 4 mM EDTA, 0.2% bromophenol blue, 0.2% xylene cyanol, 25% glycerol) was added to the samples, which were then loaded onto a 4% acrylamide-Tris-acetate-EDTA gel. The bound and unbound fragments were separated by electrophoresis at 10 or 15 V/cm for 1 h at 4°C. Gels were stained with ethidium bromide, and the DNA was detected by UV fluorescence.
The identity of the band resulting from the binding of a dimer of NAC was determined from the mobility of a shift induced by NAC L111K , which is known to bind as a dimer (38) . The identity of the band resulting from the binding of either two dimers or a tetramer that does not bend the DNA was determined from the mobility of the shift of a nac fragment induced by NAC L111K , where two dimers bind (37, 38) , or from the mobility of a cod fragment bound by NAC WT , which binds as a tetramer with little bending of the DNA (37) . The identity of the band resulting from the binding of a tetramer that bends the DNA was determined from the mobility of the shift of a nac fragment induced by the binding of NAC WT , which causes a significant bend in the DNA (9, 38) . DNase I footprint assay. DNase I footprint analysis was performed as described previously (13) . In brief, 10 g of plasmid pCB1560 was digested with BamHI and labeled with [␣- 32 P]dATP in the presence of Klenow fragment, followed by a second digestion with XbaI. This generated two DNA fragments, a long fragment containing the NBS hutU and a short DNA fragment of less than 25 bp, which ran off the bottom of the gel. Approximately 0.3 pmol of labeled DNA was incubated with His-tagged NAC for 20 min, and then 1.7 ϫ 10 Ϫ4 U of DNase I (Promega) was added and the incubation was continued for another 3 min at room temperature. Digestion was stopped with a loading buffer containing 40 mM Tris-HCl (pH 8.4), 4 mM EDTA, 0.2% bromophenol blue, 0.2% xylene cyanol, 25% glycerol, and 50% formamide. Digestion products were separated by electrophoresis on a 6% urea-Tris-borate-EDTA sequencing gel at 1,200 V for about 4 h. The gel was dried on Whatman 3MM paper and exposed to X-ray film. A "G ladder" was prepared with 0.3 pmol of labeled DNA as described previously (1).
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RESULTS
Alanine scanning mutagenesis of the N-terminal domain of NAC. At many of the sites where NAC activates transcription, NAC functions as a dimer; at many of those sites, an Nterminal fragment of NAC containing as few as 86 amino acids is able to bind and activate transcription (31, 38) . Our goal was to identify features of NAC required for activation. Therefore, we performed alanine scanning mutagenesis of the amino acids 2 through 100, generating a set of 89 substitution mutants, each with a single amino acid changed to alanine (there are 10 alanines native to this region of NAC). The DNA sequence of each mutant nac gene was determined and the mutant gene was cloned into a plasmid under the control of the lac promoter as described in Materials and Methods. The expression of NAC WT from this plasmid is sufficient to activate all known NAC-dependent genes. The ability of NAC to activate gene expression was initially determined by measuring the activity of histidase formed (from the hut operon), and the ability of NAC to repress gene expression was determined by measuring the activity of glutamate dehydrogenase formed (from the gdhA gene), as shown in Table 1 . About one-third of the substitutions in the first 86 amino acids were essentially wild type, activating hut and repressing gdhA about as well as the wildtype NAC protein did. All of the substitutions in amino acids 87 to 100 were essentially wild type. This was expected, since this region functions as a linker between the two independent domains of LTTRs. Moreover, NAC mutants with only the N-terminal 86 amino acids are able to activate hutUp and ureDp almost as well as wild-type NAC.
Substitutions that inactivate NAC. It requires more NAC to activate hut operon expression than to regulate other genes (41) , and so we were concerned that mutants showing less histidase activity than the wild type might result from a partially defective NAC or a more unstable NAC that accumulated to lower levels. Therefore, for every substitution with lower-than-wild-type levels of histidase (specific activity of less than 220 nmol/min/mg of protein), we also assayed urease from the ure operon, which has been shown to be activated by very low levels of NAC, less than or equal to the amount required to repress gdhA (41) . This allowed us to distinguish between mutants with the phenotype expected of an inactive NAC (urease activity less than 125 and GDH greater than 600 nmol/ min/mg of protein) from those with a partial phenotype (urease activity greater than 125 or GDH less than 600 nmol/ min/mg of protein). By this definition, only 19 of the substitution mutants showed the phenotype of a completely inactive NAC (Table 1) .
A simple explanation for a lack of function in a mutant protein is that the protein is degraded and does not accumulate in the cell. NAC WT is known to be rather unstable (30) and is degraded in chloramphenicol-treated cells with a half-life of about 10 min (data not shown). To eliminate the trivial case where there was no NAC function because no NAC polypeptide was present in the cells, we performed a qualitative Western blot assay on the 19 mutant strains that showed neither significant activation nor significant repression by NAC ( Table  1) . Six of those, with alanine substitutions of amino acids N2, L3, L6, F9, D14, and L32, gave no signal in the Western blot probed with polyclonal anti-NAC antibody. Five of these were clustered in an N-terminal region that is highly conserved among LTTRs and corresponds to an important ␣-helix in the known structure of CbnR (29) . We had noted previously that modifications of the N terminus of NAC led to inactivation of NAC's function (31) . Taken together, these data suggest that the N-terminal region of NAC (corresponding to the ␣1-helix of CbnR and other LTTRs) is important for structural integrity.
The DNA-binding domain of NAC (amino acids 1 to 86) contains 11 leucine residues. Leucine-to-alanine substitution of seven of them (residues 3, 6, 18, 32, 39, 47, and 48) led to a complete loss of NAC function. (NAC L80A had wild-type function; NAC L25A , NAC L64A , and NAC L72A retained partial activity.) Of the seven substitutions that eliminated NAC function, three of them (L3A, L6A, and L32A) were not detectable in our Western blot assays, and the remaining four, as well as the three with partial activity, showed a significant reduction in the NAC signal ( Table 1 ), suggesting that these substitutions led to a NAC that was even more unstable than NAC WT . Whatever the cause of the reduced signal in our Western blotting results may have been, it is clear that the leucine residues in NAC's DNA-binding (and activation) domain play an important structural role.
Two of the alanine substitutions that lacked NAC activity but showed at least some signal in our Western blot assays were chosen for further study: Q29A, a highly conserved residue that was expected to lie in the helix-turn-helix (HTH) region, and I71A, which was expected to lie within the dimerization helix region. Many mutant NAC proteins cannot be purified by our standard purification procedure. Therefore, all in vitro experiments were performed with His-tagged variants of the NAC protein under study. We have shown elsewhere (36) that NAC and His-tagged NAC give the same gel shifts and DNase I footprints. In vivo, His-tagged NAC gives stronger activation of hutUp and stronger repression of gdhAp under conditions of moderate nitrogen limitation. The reason for this increased activity is unknown, but it may reflect the fact that purified His-tagged NAC is more resistant to at least one protease in vitro than untagged NAC (30) . Therefore, in vivo experiments were performed with proteins lacking the His tag.
Effect of the Q29A substitution on NAC binding. The glutamine at position 29 is conserved among many LTTRs and is located at the beginning of the second helix of the HTH motif (21, 29, 39) , despite the presence of a conserved proline in position 30. Western blotting results suggested that NAC Q29A is present in cells carrying the substitution (Table 1) and at levels comparable to NAC WT (data not shown). We cloned the Q29A mutant gene encoding a C-terminal His tag, purified the resulting protein by nickel affinity chromatography, and compared its ability to bind the NBS hutU in an EMSA. As shown in Fig. 1A , binding of NAC WT resulted in a single shifted band whose mobility has been shown to represent a dimer of NAC bound to DNA (37, 38) . In contrast, only in a significant excess of NAC Q29A was a shifted band observed, and that shifted band had a mobility consistent with a tetramer of NAC bound to the DNA. Such a "tetramer shift" is also seen with NAC WT when NAC is in significant excess (Fig. 1A ) and represents the ability of NAC to bind to almost any AT-rich DNA ("pseudosites") if the concentration of NAC is high enough (see below). Such a shift has a mobility expected of a tetramer WT to bind as a tetramer but also to bend the DNA significantly (8, 37, 38) . Figure 1B shows that NAC WT bound almost exclusively as a tetramer in this experiment with only a trace band representing dimeric NAC bound to DNA. In contrast, NAC Q29A yielded almost no shifted material, and such shifted material as was seen had a mobility characteristic of a tetramer of NAC bound to DNA without bending the DNA (38) .
Dimers of NAC Q29A did not bind tightly enough to the site at hut to be detected by EMSA. However, a band with the mobility expected of a tetramer was detected at higher concentrations of NAC Q29A , suggesting that NAC Q29A does retain some specific binding affinity. The DNase I footprint in Fig. 2 (lanes 3 to 6) shows that when NAC WT was present in excess, it strongly protected the known NBS hutU (indicated by the thick line in Fig. 2 ) as well as a nonconsensus site with no regulatory significance (indicated by the thin line in Fig. 2 ). The latter site (approximately Ϫ18 to ϩ18 in Fig. 2 ) appears to bind a NAC WT tetramer even in the absence of the strong site if NAC WT is in excess (Fig. 3) . NAC Q29A also showed protection of the known NBS hutU but only at a higher concentration of NAC (Fig. 2, lanes 7 to 10) . Thus, the Q29A substitution The specific activities of histidase, GDH, and urease are the means of assays from three independent cultures. In every case the SEM was less than 20%. c The apparent activity of NAC in cells bearing the indicated substitution. "Wild type" indicates that the activation levels of histidase and urease and the repression of GDH expression were similar to those seen in the strain carrying pCB1051 (which carried a wild-type copy of nac cloned in pCB1041). "Partial" indicates that activation levels of urease, repression of GDH, or both were less than wild type. "None" indicates that the strain resembled the negative control bearing the empty vector pCB1041.
d Western blots were performed on samples from most strains with defects in NAC regulation. ϩ, approximately as much signal as wild type; ϩ/Ϫ, a signal was easily visible but less intense than that seen with wild-type cells on the same blot; Ϫ, no signal was detected. For reasons that are unclear, the strain expressing the R5A substitution gave a noticeably stronger signal in the Western blot than the wild type, and this is indicated by ϩϩ in the table. ND, not determined. appears to significantly reduce the affinity of NAC for its normal binding sites, consistent with its presumed position in the HTH region of the DNA-binding domain of NAC.
A NAC dimer can interact weakly with almost any AT-rich DNA, but this interaction is too weak to be detected under our EMSA conditions unless NAC is present in considerable excess. We have shown that the specific binding of a NAC tetramer at a true NBS involves three sets of interactions: two of them involve the interaction of each dimer with its specific NBS and the third involves the interaction between the two dimers within the tetramer (37) . If one of those three interactions is weak, a NAC tetramer can still bind, but the binding is not strong enough to bend the DNA (37) . Thus, it is not surprising that the NAC bound to weak sites (AT rich but lacking specific sequences) appears as a bound tetramer, where each dimer contributes a small amount of binding energy. The binding of either NAC WT or NAC Q29A to the fragment lacking a specific NBS most likely represents such a nonspecific affinity for AT-rich DNA.
While it is not surprising that a substitution in the helix-turnhelix (DNA-binding) region of the protein would affect the ability of NAC to recognize its specific sites, it does not necessarily mean that Q29 interacts directly with DNA. In fact, the crystal structure of the related LTTR, CbnR, suggests that the side chain of Q29 is directed away from the DNA and into the body of the N-terminal domain of the protein (29) . So, it is more likely that the Q29A substitution distorts the general structure of the DNA-binding domain in ways that reduce specific binding more than nonspecific binding. NAC I71A is monomeric. NAC I71A was also cloned with a C-terminal His tag and purified by nickel affinity chromatography. The structure of CbnR suggests that the amino acid corresponding to I71 should lie solidly within the long helix responsible for holding the monomers of LTTRs together in the dimer (42) . Therefore, we used FPLC to compare the apparent size of the His-tagged NAC I71A to His-tagged versions of NAC WT and NAC L111K (Fig. 4) Fig. 3 ). The numbers represent the position of the nucleotides relative to the start of transcription. Arrowheads indicate sites of DNase I hypersensitivity.
FIG. 3. Binding of NAC
WT to a nonconsensus site on DNA. Nonradioactive EMSA of DNA fragments with (lanes 1 to 4) or without (lanes 5 to 8) an NBS. DNA for lanes 1 to 4 was PCR amplified from plasmid pCB648 (34) , which carries the NBS from hut. DNA for lanes 5 to 8 was PCR amplified from plasmid pCB903 (35) , in which the NBS in pCB648 was "scrambled" by reversing the sequence without reversing the 5Ј-to-3Ј orientation. Thus, the NAC-binding sequence ATAA CAAAATTGTAT in pCB648 is replaced by TATGTTAAAACA ATA, which does not bind NAC (35) . Both of the amplified fragments contain the region referred to as nonconsensus in Fig. 2 I71A eluted with an apparent molecular weight of 39,800 (predicted monomer molecular weight, 33,576.8). Thus, the I71A substitution appears to interfere with NAC's ability to form dimers and hence the tetrameric "dimer of dimers" characteristic of LTTRs. NAC H26D can bind and repress but not activate transcription. Mutants of the carbon catabolite activator protein (CAP, also known as CRP) have been isolated that bind DNA normally (and repress transcription) but cannot activate transcription (15) . Since these mutants are defective in positive control of transcription but not in negative control, they have been called "positive control" or PC mutants (15) . Many of the PC mutants of CAP are altered in the amino acids that make direct contact with RNA polymerase (5). Mutants of two other LTTRs, GcvA and CysB, have been reported to bind DNA normally but fail to activate transcription (19, 21) . By analogy to CAP, these have been assumed to affect amino acids involved in contacting RNA polymerase, but there is no direct evidence for this in any LTTR.
Somewhat surprisingly, our alanine scan of the entire Nterminal domain of NAC failed to identify any substitution that resulted in a PC phenotype, leaving us with no candidates for amino acids that might be required for contact with RNA polymerase. The reported PC mutants of GcvA and CysB are altered at the amino acid corresponding to H26 in NAC. Therefore, we isolated a collection of nac mutants that changed H26 to each of the other 19 possible amino acids. Each of these mutant nac genes was cloned and tested in a Nac Ϫ strain for the ability to activate hut expression, measured as histidase formation, and repress gdhA expression, measured as glutamate dehydrogenase (GDH) formation ( Table 2) . Seven of the mutants (the bottom seven in Table 2 ) failed to repress gdhA significantly or activate hut. These were assumed to yield inactive or unstable NAC and were not studied further. Another nine showed at least a 2-fold activation of hut (relative to the empty vector control) and were also not studied further (the nine listed below the vector and wild type in Table 2 ). However, three of the mutants showed strong repression of gdhA with weak or no activation of hut and were candidates for PC mutants.
In vivo, more NAC is required to activate hut than to repress gdh (41) . Thus, the NAC in the putative PC mutant strains might merely be less stable or less active than wild type, resulting in enough active NAC to repress gdh but not enough to activate hut. Alternatively, a PC candidate might be generally defective in its ability to activate transcription. To distinguish between these possibilities, we assayed two candidates, H26W and H26D, for activation of ure operon expression. In vivo, at least as much NAC is required to repress gdh as to activate ure (41) . Thus, repression of gdh shows that there is sufficient active NAC to activate ure, and failure to activate ure suggests a defect in the ability to activate rather than a deficiency of active NAC caused by an unstable or less active NAC. The Nac Ϫ strain with an empty vector had a urease specific activity of 51 nmol/min/mg of protein. With NAC WT on the plasmid, the specific activity was 1,600 nmol/min/mg of protein. With NAC H26W on the plasmid, the specific activity of urease was 1,900 nmol/min/mg of protein, and with NAC H26D the specific activity was 68 nmol/min/mg of protein. Thus, NAC H26D met our criteria for a PC mutant in that it failed to activate ure expression even though there was sufficient active NAC present to repress gdh expression. However, the fact that the H26A substitution was indistinguishable from wild type suggests that the role of H26 may be something other than to provide a required contact with RNA polymerase.
EMSA confirmed that NAC H26D binds to NBSs even though it fails to activate ure or hut expression in vivo. Figure 5A shows that both NAC WT and NAC H26D gave the same shifted species of ure DNA and that all the ure DNA was shifted except at the lowest concentration used here. The situation with hut was more complex. Although NAC H26D bound to hut DNA (shown by the disappearance of the unshifted band in Fig. 5A ), it did not yield a discrete band. The shifted band was diffuse and did not account for all the DNA missing from the unshifted material, suggesting that the complex was not stable during electrophoresis. However, the DNase I footprint of NAC H26D on hut DNA is very similar to that of NAC WT (Fig. 6) . Thus, NAC H26D fits the formal definition of a PC mutant in the sense that it binds to DNA and represses transcription but fails to activate transcription, although the binding may not be the same as wild type.
Substitutions affecting NAC tetramer formation. LTTR tetramers generally assemble in an extended conformation that binds to a longer DNA-binding site, where the two dimerbinding sites are separated by some distance and formation of the complex results in a significant bend in the DNA. In the presence of their coeffectors, they assume a more compact conformation that binds to a shorter DNA site, where there is a The mutant nac alleles were cloned in the low-copy-number vector pCB1041 and transferred into the Nac Ϫ strain KC4598. b Cells were grown and assayed for histidase and GDH activities as described in Materials and Methods. Specific activities reported are the means of at least three independent experiments, with SEM of less than 15% of the means.
less distance between the dimer-binding sites and the DNA bend angle is reduced (39) . We have shown that NAC can bind to both a longer and a shorter DNA site, and we have suggested that this means that NAC can assume both the extended and compact conformations typical of other LTTRs (29, 39, 42) . In order to support the argument that the conformations that NAC can assume are indeed different and correspond to those of other LTTRs, we sought mutants that might distinguish one conformation from the other. We had already shown that substitutions affecting amino acids 111 and 125 (NAC L111K and NAC L125R ) prevent NAC dimers from assembling into tetramers (38) . Biochemical and structural studies of OxyR suggested that amino acids I110 and L124 (corresponding to L111 and L125 in NAC) and the region containing amino acids 219 to 233 make up a tetramerization domain of OxyR (6) . The crystal structures of OxyR show that I110 and L124 in one subunit of OxyR interact with A233 in the other subunit in the reduced form (the extended form that recognizes the longer site and bends the DNA) and with F219 in the other subunit in the oxidized form (the compact form that recognizes the shorter site and bends the DNA less dramatically). Lochowska et al. showed that the A227D substitution of CysB (corresponding to amino acid I222 of NAC) also fails to bend the DNA to which it binds (21), suggesting a defect in one conformation of CysB.
Substitutions that changed L111 or L125 in NAC to a basic amino acid prevented NAC from forming tetramers of any kind (38) . We reasoned that introducing a basic amino acid into one of the regions that can interact with the L111/L125 region might also prevent NAC from forming one or both forms of the tetramer. Therefore, we changed amino acids in the region from 217 through 233 to arginine to test for effects on tetramer conformation. The resulting mutant nac genes were cloned in plasmid pCB1026 (pQE70 with an EcoRIBamHI fragment carrying nac), which allowed expression of the cloned gene under the control of an isopropyl-␤-D-thiogalactopyranoside-inducible promoter and adds a C-terminal His tag to each protein to allow for protein isolation. Two of the mutants, NAC L225R and NAC A230R , were not stably expressed in E. coli and were not studied further.
We then tested each mutant protein for its ability to bind and bend a longer DNA site (nac) and a shorter site (cod) as described in reference 37, which also appears in this journal issue. The NAC-binding region on each DNA fragment was positioned at the center of the fragment to maximize the effect of DNA bending. Two of the mutants, NAC A227R and NAC G232R , gave the same mobility shift as wild type in this test (Fig. 7) . These mobilities have been shown to represent NAC bound as a tetramer at the longer (nac) site with a significant bend introduced into the DNA (9, 38), and NAC bound as a tetramer to the shorter (cod) site without significant bending of the DNA (32, 37) . Five other mutants, NAC I219R , NAC T224R , NAC A228R , NAC M233R , and possibly NAC S231R , appeared to be severely defective in tetramer formation and bound to both nac and cod almost exclusively as dimers. The remaining mutants showed wild-type tetramer binding to one of the sites but with some sort of defect in binding to the other. For example, NAC I222R , NAC T223R , and NAC A230R showed normal tetrameric binding to cod, but the binding to nac was aberrant in that the mobility of the shifted band did not correspond to that seen with the wild type. It was more retarded than that expected of two independent dimers of NAC L111K (seen in the lane marked 2xL111K) but less retarded than that seen with the wild type (WT lane). Apparently, NAC I222R and NAC
T223R
are not able to properly bend the nac DNA fragment, suggesting that they cannot assume the extended form of an LTTR. In contrast, NAC G217R shows a normal tetrameric shift of nac DNA with the same mobility as the (bent) wild-type complex, but binding to cod DNA left much of the material with a mobility characteristic of a dimer/DNA complex, suggesting that it cannot assume the compact form of an LTTR that binds to shorter DNA sites.
In vivo effects of tetramerization mutants. The simplest explanation for these data is that some of these mutants (e.g., NAC G217R ) might be defective in forming the compact form of a NAC tetramer that recognizes the short footprint sites, like NBS codB . Other mutants (e.g., NAC I222R and NAC A230R ) might be defective in forming the extended form of the tetramer that recognizes the long footprint sites, like NBS nac , where NAC bends the DNA to which it binds. To test whether these mutants were able to form functional tetramers of any kind in vivo, we examined the abilities of single and double mutants to repress gdhAp expression in vivo.
Each of the mutant nac genes was cloned without a His tag in the low-copy-number vector pCB1051, which allows expression of nac from the lacZ promoter. In each case, activation of hut expression was monitored by assaying histidase formation to guarantee that defects in gdhAp repression did not result from a less stable or less active NAC. (Recall that more NAC is required to activate hutUp in vivo than to repress gdhAp and that activation of hutUp does not require tetramer formation.) There are two different forms of repression exerted by NAC at gdhA. In the absence of NAC, ArgP binds to a site upstream from the gdhA promoter and activates gdhA expression about 2.5-to 3-fold (12, 17) . The binding of a dimer of NAC to this same site prevents ArgP binding and activation and thus reduces GDH expression about 2.5-to 3-fold. We refer to this as "weak repression." The effect of this weak repression can be mimicked by the addition of lysine to the growth medium, since lysine prevents ArgP from binding and activating (12) . An independent effect occurs when a second dimer of NAC binds to a site downstream from the promoter. If the NAC is able to form a tetramer, then a much stronger, 10-fold repression of gdhA expression is observed (14) . Mutants that cannot form tetramers do not exert this "strong repression" (38) . Thus, the in vivo tests monitor two functions of NAC: binding to the site upstream from gdhA and tetramerization of NAC. These data are presented in Table 3 .
FIG. 7. Binding of NAC mutants to the (longer) NBS
nac and the (shorter) NBS codB . The specific activities of the mutant proteins are unknown, and so approximately 30 to 45 ng of the 150-bp fragments amplified from the nac and cod promoter regions was mixed with enough mutant protein to shift about 50% of the DNA. NAC WT was included to indicate the mobility of the complex with the longer site from nac, which is significantly bent, and NAC L111K is included to indicate the mobility of a dimer bound at nac or cod. Lanes marked 2xL111K have twice as much NAC L111K , to indicate the mobility of a fragment containing two dimers of NAC. The letters to the left of the gels indicate the mobilities associated with the unshifted DNA (U), the DNA bound by a dimer (D), and the DNA bound by a tetramer (T). For the upper (nac) panels, the tetramer-associated mobility covers a range between that represented by two dimers of NAC L111K (minimum bending of the DNA) and that represented by NAC WT (significant bending of the DNA).
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Most of the mutants were relatively good at activating histidase formation. Only two of the mutants, those carrying the T223R and A227R substitutions, showed less than half the wild-type level of histidase activity. We did not consider these two mutants further. Three of the substitutions shown in Table  3 (I219R, T224R , and A228R) appeared to be unable to form tetramers of either type effectively (Fig. 7) . These showed the weak repression of GDH expression but not the strong repression. The remaining substitutions showed the strong repression of GDH repression, which we have shown to require tetramer formation (38) . Note that this group included NAC G217R , which had difficulty assuming the compact form of the tetramer, which recognizes shorter DNA sites. It also included NAC I222R and NAC A230R , which had difficulty forming the fully bent extended form of the tetramer, which recognizes longer DNA sites. We also generated two additional substitutions, I222S and A230S, which have less drastic substitutions than their counterparts I222R and A230R. These mutants also showed strong repression of GDH expression, suggesting tetramer formation. We interpret these data as indicating that the DNA loop presumed to be required for strong gdhAp repression can be formed by either the compact form of the tetramer (using an interaction between the L111/L125 region of one subunit and the G217 region of the other) or by the extended form of the tetramer (using an interaction between the L111/ L125 region and the I222/A230 region). If this interpretation is correct, then a double mutant carrying a G217R substitution and either an I222R or an A230R substitution should be unable to form either type of tetramer and thus should be as defective in gdhAp repression as NAC L111K (38) . Double mutants carrying the G217R substitution and either I222R or A230R were tested, as were the equivalent double mutants with G217R and I222S or A230S. All four of the double mutants showed activation of hut, although G217R A230S seemed less effective in this activity. However, all four of the double mutants failed to show strong repression of GDH expression (suggesting lack of tetramer formation), even though weak repression was intact (showing binding of dimers to be intact).
DISCUSSION
When this work was initiated, the CbnR protein was the only LTTR for which a high-resolution structure of the entire tetrameric protein existed (29) . Since then, two additional structures of typical LTTRs have been solved (28, 48) . Although subtle differences exist in the structures, the general principles identified by the CbnR structure and discussed here are mirrored in these two newer structures as well. Therefore, we have used the CbnR structure as our model here. Unfortunately, there are no examples where a high-resolution structure of an intact tetramer exists in both the effector-bound and the effector-free state. However, there are high-resolution structures of the C-terminal domains of several other LTTRs, and for some of these, e.g., OxyR (6) and DntR (42) , the orientation of the monomers at the tetrameric interface has been determined under conditions that correspond to the extended and compact forms of the tetramer. It is clear that the structural conservation among the LTTRs is even higher than the conservation of primary sequence. For example, the C-terminal domain of a All nac genes were cloned in the low-copy-number vector and transferred into the Nac Ϫ strain KC4727 (hutC515 ͓⌬bla-2͔ nac-204::plac Mu53). Cells were grown and assayed for histidase and GDH activities as described in Materials and Methods.
b The presence or absence of L-lysine (0.01%, wt/vol) in the growth medium. The presence of lysine mimics the weak repression caused when NAC binds to the gdh promoter by preventing ArgP-mediated activation of gdh expression (12, 17) .
c Specific activities reported are the means of at least three independent experiments, with SEM of less than 15% of the means. ND, not determined.
BenM shares only 12% and 21% amino acid identity with the C-terminal domains CysB and OxyR, respectively. However, the ␣-carbon backbone of the C-terminal domain of BenR, when aligned with the C-terminal domains of CysB and OxyR, shows average root mean square deviations of only 2.6Å and 2.5Å, respectively (7). This surprising conservation of structure makes it possible to use the structures of CbnR and OxyR to suggest interpretations for the phenotypes of the NAC substitutions described here.
The Q29A substitution, which greatly reduces the affinity of NAC for its specific binding site (though not for nonspecific binding) lies in the predicted helix-turn-helix region. The I71A substitution, which prevents dimerization of NAC monomers, lies in the middle of the predicted dimerization helix. The H26D substitution, which fails to activate hut expression but still binds at hut and both binds and represses at gdhA, affects the same amino acid as the PC mutants of GcvA and CysB (19, 21) . All of these findings suggest that, at least to a first approximation, the structure of NAC is typical of other LTTRs.
We were initially surprised that the alanine scanning mutagenesis did not yield any PC mutants. Therefore, we, like others (21), followed the example of GcvA and looked at amino acid H26, equivalent to the F31 of GcvA, where the PC mutant was found (19) . Of all the amino acid changes possible at H26, only the replacement of histidine with an acidic amino acid (H26D or H26E) resulted in a PC phenotype. The other candidate for PC in Table 1 , H26W, was fully able to activate urease. We have not determined whether H26W is specifically defective in its ability to activate hut expression or whether it simply produces too little NAC to activate hut but still produces enough to activate ure and repress gdhA. We also noted that the binding of NAC H26D was less stable in the EMSA than NAC WT , even though the DNase I footprint appeared normal. The location of H26, at the edge of the first helix of the HTH motif, just before the turn, is curious. It seems an unusual location for an amino acid located so close to the DNA in the HTH motif to be in contact with RNA polymerase. It is also curious that so many substitutions at H26, including H26A, were essentially wild type for activation. This is not the behavior expected of an amino acid residue that makes an essential contact with RNA polymerase. Moreover, it is difficult to reconcile the fact that NAC activates hutUp from a site centered at Ϫ64 and ureDp from a site centered at Ϫ47 with the notion that the same H26 residue could make the essential contact with RNA polymerase (20) . Lochowska et al. (22) have shown that CysB interacts with the ␣-CTD of RNA polymerase in a two-hybrid assay and that a Y27A substitution eliminates this interaction. It remains to be seen, though, if the Y27A substitution of CysB (or the H26D substitution of NAC) defines the site of the interaction with RNA polymerase or some more general conformational defect.
We have suggested elsewhere (37) that NAC can assume two different tetrameric conformations, one corresponding to a coeffector-free LTTR and one corresponding to a coeffectorbound LTTR. This was based on the observation that NAC could bind to two different kinds of DNA sites, a shorter site with two dimer-binding sites adjacent to each other and a longer site with the two dimer-binding sites separated by about 10 bp. These would be the two kinds of sites normally recognized by the coeffector-bound and coeffector-free forms of an LTTR, respectively. However, there is no coeffector for NAC. Therefore, in order to strengthen our argument about two distinct but interconvertable conformations of NAC, we sought substitutions that would prevent NAC from assuming one or the other of the conformations. Our data suggest that G217R and I222R are just such types of a substitution. In vitro EMSAs showed that NAC G217R binds to a longer site (nac) and yields the mobility shift typical of strongly bent DNA, exactly as is seen with NAC WT . However, it has difficulty in recognizing the shorter site (cod), and much of the shifted material has the mobility of a dimer rather than of a tetramer. In contrast, NAC I222R binds normally to cod, but the binding at nac is aberrant in that the mobility of the band representing tetramers does not show the normal bend angle seen with NAC WT . One might expect that NAC G217R and NAC I222R would be defective in vivo for regulating cod and nac, respectively. However, both the activation of cod and the repression of nac can be accomplished almost as well by the dimeric form of NAC as by the tetrameric form (18, 32) , so those defects are in fact not observed.
Although the in vivo data for gdhA expression are not directly comparable to the in vitro EMSA data for nac and cod, the gdhA data argue strongly that the double mutant NAC G217R,I222R cannot form the tetramers required for the strong repression of gdh expression. However, the double mutant still retains its ability bind at gdh (presumably as a dimer) in that NAC G217R,I222R still exerts the "weak repression" that results from its ability to prevent binding of ArgP. NAC G217R,I222R can also bind and activate hut expression, again presumably as a dimer. In contrast, each of the single mutants, NAC G217R and NAC I222R , gave full repression of gdh, suggesting that tetramers were formed and were strong enough to generate the interaction between the two NBSs at gdhA that is needed for strong repression.
The effects of the G217R and I222R substitutions on gdh expression also lend support to the model that repression of gdhA requires the formation of a loop between the two separate NBSs in the gdhA region, one centered at Ϫ89 relative to the start of transcription and the other centered at ϩ57 (14) . The cartoon in Fig. 8 shows how one conformation of NAC would bind to a shorter site with little bending and to a longer site with considerable bending. If the two dimer-binding sites within a tetramer site are near each other, as in cod or nac, then the single mutants, NAC G217R or NAC I222R , should each function at one of the sites but not both. On the other hand, if the two dimer-binding sites are distant from each other as in gdh and if a loop is formed by the tetramer as part of the mechanism of repression, then either of the single mutants would be functional and it would require elimination of both conformers, as in the double mutant, to eliminate functional binding.
One final point to note is that we have shown here that at sufficiently high concentrations of NAC, binding of NAC tetramers, but not dimers, can be detected that has no physiological relevance. Such binding sites, with a range of affinities for NAC, have been seen before in places as unexpected, as with the bla gene of pUC19 (13) , and have even been footprinted at several sites (36) , showing that they are not entirely nonspecific. Nevertheless, they are unlikely to function under normal conditions, since autorepression of nac expression keeps the concentration of NAC at physiologically relevant levels in vivo (9, 25) . On the other hand, we and others have noted that artificial overproduction of NAC is quite toxic to cells (2) (3) (4) , suggesting that occupancy of some of these sites may be deleterious. This atypical binding of NAC seems to require a tetramer; we have never seen dimers binding to such sites. We assume that four monomer HTH motifs interacting weakly with DNA are sufficient to hold a tetramer, whereas two monomers interacting weakly are not sufficient to hold a dimer. In fact, this may explain why NAC functions as a dimer at many of the sites where NAC activates gene expression. Such dimerbinding sites would have to have a higher affinity for NAC and would thus be more likely to be the most specific and the first to bind NAC. In trying to identify the nucleotides important for binding of NAC, we have been surprised at the number of different sequences that can serve as a half-site for dimer binding within either a dimer-binding site or a tetramer-binding site (37) . The rules are far from clear. Although this may simply be a defect in the design of NAC, it is also possible that this is a potent evolutionary strategy, allowing NAC to bind weakly to a large number of potential promoters and then to evolve more effective binding under selective pressure. This might explain how NAC has been able to bring so many different genes into the NAC regulon of K. pneumoniae (11) . FIG. 8 . Interaction of NAC tetramers with DNA containing two dimer-binding sites. This cartoon illustrates how substitutions affecting one form of the NAC tetramer but not the other can affect NAC binding. If two dimer-binding sites were close together (as at cod), then only the compact form of NAC tetramer would be able to recognize the site. NAC G217R would not be able to make the stable interactions between the L111/L125 region of one dimer with the G217 region of the other dimer, and thus the ability to form an compact tetramer would be impeded. If two dimer-binding sites were separated by 10 bp (as at nac), then only the extended form of NAC tetramer would be able to recognize the site. NAC I222R and NAC A230R would not be able to make the stable interactions between the L111/L125 region of one dimer with the I222/A230 region of the other dimer, and thus the ability to form an extended tetramer would be impeded. However, if the two dimer-binding sites were separated by enough DNA to allow a loop to form, then either the compact or the extended form of NAC tetramer would be able to recognize the sites and form a loop. Substitutions affecting both the G217 region and the I222/A230 region would have difficulty forming stable tetramers of either configuration, similar to the mutants affecting L111 and L125, which have been shown to be dimeric. 
